Clinical Trial Update: Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin to mitigate sequelae of radioactive iodine treatment in thyroid cancer was terminated, with results subsequently posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Thyroid | Phase 2 | Status: TERMINATED | Results posted: 2025-12-11